EXTENTUS PHARMA LTD

Active Liverpool

Research and experimental development on biotechnology

2 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
E

EXTENTUS PHARMA LTD

Research and experimental development on biotechnology

Founded 20 Mar 2014 Active Liverpool, England 2 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology

Previous Company Names

TANDEM NANO LTD 20 Mar 2014 — 6 Nov 2025
Accounts Submitted 29 Apr 2026 Next due 30 Apr 2026 2 months overdue
Confirmation Submitted 21 Apr 2026 Next due 3 Apr 2027 10 months remaining
Net assets £-1M £268K 2024 year on year
Total assets £260K £37K 2024 year on year
Total Liabilities £2M £305K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

11b Liverpool Science Park Ic1 Mount Pleasant Liverpool L3 5TF England

Email

info@example.com

Website

www.example.com

Full company profile for EXTENTUS PHARMA LTD (08949503), an active life sciences and medical technology company based in Liverpool, England. Incorporated 20 Mar 2014. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Aug → 31 Jul 2024
Type total-exemption-full
Next accounts 31 Jul 2025
Due by 30 Apr 2026 2 months overdue

Net Assets, Total Assets & Total Liabilities (2015–2024)

Cash in Bank

£230.91k

Increased by £186.77k (+423%)

Net Assets

-£1.29M

Decreased by £267.80k (-26%)

Total Liabilities

£1.55M

Increased by £305.14k (+25%)

Turnover

N/A

Employees

2

Debt Ratio

595%

Increased by 37 (+7%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Jul Year End
2023
31 Jul Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

2 active 1 resigned
Status
Broughton, Nicola Ann, DrDirectorBritishUnited Kingdom541 Aug 2024Active
Nolan, EmmaDirectorBritishEngland5622 Jan 2018Active

Shareholders

Shareholders (14)

University Of Liverpool
54.4%
Andrew Owen
15.7%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

University Of Liverpool

United Kingdom

Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 50 To 75 Percent,voting Rights 50 To 75 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
19 May 2026CapitalCapital Alter Shares Subdivision
29 Apr 2026AccountsAnnual accounts made up to 31 Jul 2025
21 Apr 2026Confirmation StatementConfirmation statement made on 20 Mar 2026 with updates
2 Mar 2026IncorporationMemorandum Articles
6 Nov 2025Change Of NameCertificate Change Of Name Company
19 May 2026 Capital

Capital Alter Shares Subdivision

29 Apr 2026 Accounts

Annual accounts made up to 31 Jul 2025

21 Apr 2026 Confirmation Statement

Confirmation statement made on 20 Mar 2026 with updates

2 Mar 2026 Incorporation

Memorandum Articles

6 Nov 2025 Change Of Name

Certificate Change Of Name Company

Recent Activity

Latest Activity

Capital Alter Shares Subdivision

2 weeks ago on 19 May 2026

Annual accounts made up to 31 Jul 2025

1 months ago on 29 Apr 2026

Confirmation statement made on 20 Mar 2026 with updates

1 months ago on 21 Apr 2026

Memorandum Articles

3 months ago on 2 Mar 2026

Certificate Change Of Name Company

7 months ago on 6 Nov 2025